SUBSCRIBE
SUBSCRIBE

Food and Drug Administration (FDA)

NEWS
Genetown
What 29 Drugs Face FDA Approval in 2012?
May 3, 2012
 · 
1 min read
BioCapital
FDA Plans ID-Tag System to Detect Faulty Devices
April 26, 2012
 · 
1 min read
BioCapital
How the FDA Stifles New Cures, Part II: 90% of Clinical Trial Costs are Incurred in Phase III
April 26, 2012
 · 
1 min read
BioCapital
How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials
April 25, 2012
 · 
1 min read
BioCapital
FDA Says Nanotech May Need Extra Safety Tests
April 23, 2012
 · 
1 min read
BioCapital
FDA Says Focused on Tracking Drugs After Approval
April 23, 2012
 · 
1 min read
BioCapital
Transvaginal Mesh Injuries Ruin Lives, FDA Slow to React
April 11, 2012
 · 
1 min read
Policy
FDA Workers Pressured to Approve Unsafe Medical Devices
April 9, 2012
 · 
1 min read
Policy
Former FDA Chief Scientist Presents 10 Points for Regulatory Reform
April 6, 2012
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
June 29, 2026
 · 
6 min read
Press Releases
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
June 29, 2026
 · 
7 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
June 29, 2026
 · 
14 min read
Press Releases
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
June 29, 2026
 · 
14 min read
Press Releases
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
June 28, 2026
 · 
13 min read
Press Releases
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
June 28, 2026
 · 
4 min read
Press Releases
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 28, 2026
 · 
6 min read
Press Releases
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera
June 26, 2026
 · 
5 min read
Press Releases
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
June 26, 2026
 · 
4 min read
Press Releases
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
June 25, 2026
 · 
19 min read
Load More